
A2M 1H2022 earnings preview: Where next for A2M stock?
The A2 Milk Company Limited (A2M) is a dual-listed NZX and ASX 50 public listed company that commercialises intellectual property relating to A1 protein-free milk that is sold under the a2 and a2 Milk brands as well as the milk and related products such as infant formula.
Share this:
Its products are sold primarily in Australia, New Zealand, Greater China, and North America. A2M reports its half-year numbers on Monday, the 21st of February.
By its own admission, A2M has had an extraordinary journey, disrupted in FY 2021 by the arrival of COVID 19. Initially, A2M sales surged on a wave of panic buying, prompting A2M to upgrade its full-year earnings guidance in April 2020 by 32%.
Soon afterward, A2M experienced a drastic reversal of fortune, and the share price fell by over 75%. The closure of international borders bought the daigou/reseller channel to a halt that accounted for 60-70% of A2M’s revenue from Great China. And lower birth rates in China negatively impacted the size and growth of the China infant nutrition market.
The company has since acted to address the disruption, writing down excessive stock and bolstering its leadership team. Key to the companies turnaround will be building on its relatively small market share in China.
The company has long been touted as a takeover target. In August 2021, Nestle was reportedly taking a close look at A2M and, more recently, a rumour that Canadian dairy giant Saputo was a potential suitor. No bid has as yet has come from either rumours.
Analysts expect net profits after tax (NPAT) of NZ$60 million for 1HY22, a 50% reduction on the NZ$120 million of NPAT reported in 1HY21.
A2M Share Price Chart
After falling from a high of $20.05 in June 2021, the share price of A2M has settled into a range the past nine months, with support viewed near $5.00 and resistance viewed at $7.40ish.
Providing support at $5.00 holds another test of the $7.40 area is likely in the coming months, and as such, the bias is to be long A2M at current levels.
Source Tradingview. The figures stated areas of the 15th of February 2021. Past performance is not a reliable indicator of future performance. This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation
How to trade with City Index
You can trade with City Index by following these four easy steps:
- Open an account, or log in if you’re already a customer
• Open an account in the UK
• Open an account in Australia
• Open an account in Singapore
- Search for the company you want to trade in our award-winning platform
- Choose your position and size, and your stop and limit levels
- Place the trade
Its products are sold primarily in Australia, New Zealand, Greater China, and North America. A2M reports its half-year numbers on Monday, the 21st of February.
By its own admission, A2M has had an extraordinary journey, disrupted in FY 2021 by the arrival of COVID 19. Initially, A2M sales surged on a wave of panic buying, prompting A2M to upgrade its full-year earnings guidance in April 2020 by 32%.
Soon afterward, A2M experienced a drastic reversal of fortune, and the share price fell by over 75%. The closure of international borders bought the daigou/reseller channel to a halt that accounted for 60-70% of A2M’s revenue from Great China. And lower birth rates in China negatively impacted the size and growth of the China infant nutrition market.
The company has since acted to address the disruption, writing down excessive stock and bolstering its leadership team. Key to the companies turnaround will be building on its relatively small market share in China.
The company has long been touted as a takeover target. In August 2021, Nestle was reportedly taking a close look at A2M and, more recently, a rumour that Canadian dairy giant Saputo was a potential suitor. No bid has as yet has come from either rumours.
Analysts expect net profits after tax (NPAT) of NZ$60 million for 1HY22, a 50% reduction on the NZ$120 million of NPAT reported in 1HY21.
A2M Share Price Chart
After falling from a high of $20.05 in June 2021, the share price of A2M has settled into a range the past nine months, with support viewed near $5.00 and resistance viewed at $7.40ish.
Providing support at $5.00 holds another test of the $7.40 area is likely in the coming months, and as such, the bias is to be long A2M at current levels.
Source Tradingview. The figures stated areas of the 15th of February 2021. Past performance is not a reliable indicator of future performance. This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation
- Open a Forex.com account, or log in if you’re already a customer.
- Search for the pair you want to trade in our award-winning platform.
- Choose your position and size, and your stop and limit levels.
- Place the trade.
Related tags:
Open an account in minutes
Experience award-winning platforms with fast and secure execution.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

Nvidia Earnings Preview: NVDA’s First Test of the Post Jenson Huang Era
Nvidia is expected to report $2.47 in EPS on $108.8B in revenue this quarter, but investors will be more interested in the company's guidance after the unexpected departure of founder and CEO Jenson Huang.

Nvidia Holds Support Ahead of Earnings as Nasdaq 100 Rebounds
Nvidia shares approach major support as selling pressure eases, while the Nasdaq 100 rebounds. Could upcoming earnings fuel a broader recovery?

S&P 500 Analysis: Earnings Uncertainty Continues to Weigh on the SPX
The trading week is coming to an end, and a phase of weakness remains evident across the S&P 500 in the short term. Recent price action reflects this dynamic, with SPX losing more than 2.00% over the last two trading sessions, bringing selling pressure back into focus.
StoneX Financial Ltd (trading as "FOREX.com") is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, FOREX.com does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date.
This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it. No opinion given in this material constitutes a recommendation by FOREX.com or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although FOREX.com is not specifically prevented from dealing before providing this material, FOREX.com does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation. For further details see our full non-independent research disclaimer and quarterly summary.








